Comparative study of Ashwagandha Standardized Extract for its effect on quality of life in patients during post-COVID19 period
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2022/06/043570
- Lead Sponsor
- D Y Patil Medical College Hospital and Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 52
1. Subjects of either gender, aged 18 to 50 years
2. All adult patients aged >=18 years who present to the site for follow-up OPD
3. Laboratory-confirmed COVID-19 infection with SARS-CoV-2
4. Patients who agree to follow-up for up to six months.
5. Subjects able to understand and complete the study questionnaires
6. Subjects who sign the informed written consent
1. Patients aged below 18 years will be excluded.
2. Unwilling or unable to provide written informed consent,
3. Pregnant or breast-feeding women or women with positive urinary pregnancy test at
screening.
4. Those who cannot be relied upon to comply with the test procedures or are unwilling to
give informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method